Home › Funds › Ramiah Investment Group › BIIB

Ramiah Investment Group position in BIIB

BIOGEN INC · Health Care

Ramiah Investment Group reported holding 1,994 shares of BIIB (BIOGEN INC) in its Q3 2026 13F filing — a position valued at US$450K, representing 0.35% of its reported portfolio and ranking #40 among its reported holdings. Ramiah Investment Group has disclosed BIIB holdings in 6 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)1.99K sh
Reported value held$450.40K
Portfolio Weight0.35%
First reportedQ2 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Ramiah Investment Group's BIIB position evolved

Ramiah Investment Group first disclosed a stake in BIIB in Q2 2024 at 3,536 shares (US$820K). Across 6 filings, Ramiah Investment Group increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,994 shares valued at US$450K — a reduction of -91 shares quarter over quarter.. Notable position changes include a 36% trim in Q3 2024 (shares fell 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 3.54K $819.72K New
Q3 2024 2.25K $436.92K Reduce
Q4 2024 2.49K $381.38K Add
Q1 2025 3.07K $420.51K Add
Q2 2026 2.08K $450.49K New
Q3 2026 1.99K $450.40K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIIB and 13F data

BIIB (BIOGEN INC) is a Health Care company. 20 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.43B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIIB

All BIIB fund holders →

FAQ

How long has Ramiah Investment Group held BIIB?

Ramiah Investment Group has disclosed BIIB holdings in 6 of the last 10 reported quarters, going back to Q2 2024.

What is Ramiah Investment Group's current position in BIIB?

As of Q3 2026, Ramiah Investment Group holds 1.99K shares of BIIB (BIOGEN INC), valued at $450.40K, representing 0.35% of its reported portfolio and ranking #40.

Has Ramiah Investment Group been buying or selling BIIB?

In the latest 13F filing (Q3 2026), Ramiah Investment Group reduced its position in BIIB.

Which other funds hold BIIB?

Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.